1997
DOI: 10.1097/00004647-199701000-00008
|View full text |Cite
|
Sign up to set email alerts
|

Examination of Potential Mechanisms in the Enhancement of Cerebral Blood Flow by Hypoglycemia and Pharmacological Doses of Deoxyglucose

Abstract: Cerebral blood flow (CBF) rises when the glucose supply to the brain is limited by hypoglycemia or glucose metabolism is inhibited by pharmacological doses of 2-deoxyglucose (DG). The present studies in unanesthetized rats with insulin-induced hypoglycemia show that the increases in CBF, measured with the [14C]iodoantipyrine method, are relatively small until arterial plasma glucose levels fall to 2.5 to 3.0 mM, at which point CBF rises sharply. A direct effect of insulin on CBF was excluded; insulin administe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
29
0

Year Published

1999
1999
2022
2022

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 35 publications
(31 citation statements)
references
References 34 publications
(7 reference statements)
2
29
0
Order By: Relevance
“…This is consistent with other reports showing bradycardia during either acute or chronic severe hypoglycemia in rats (Bryan and Pelligrino, 1988;Bryan et al, 1994). At the level of hypoglycemia (o2.0 mmol/L) achieved in our model, it is also assumed that there would be an abrupt increase in cerebral blood flow, as shown by other investigators (Bryan et al, 1994;Horinaka et al, 1997;Choi et al, 2001). Using nuclear magnetic resonance spectroscopy to measure brain glucose levels, the cerebral blood flow increase during hypoglycemia occurs at a plasma glucose threshold of 2.0 mmol/L, at which point the brain glucose concentration approaches zero (Choi et al, 2001).…”
Section: Discussionsupporting
confidence: 94%
“…This is consistent with other reports showing bradycardia during either acute or chronic severe hypoglycemia in rats (Bryan and Pelligrino, 1988;Bryan et al, 1994). At the level of hypoglycemia (o2.0 mmol/L) achieved in our model, it is also assumed that there would be an abrupt increase in cerebral blood flow, as shown by other investigators (Bryan et al, 1994;Horinaka et al, 1997;Choi et al, 2001). Using nuclear magnetic resonance spectroscopy to measure brain glucose levels, the cerebral blood flow increase during hypoglycemia occurs at a plasma glucose threshold of 2.0 mmol/L, at which point the brain glucose concentration approaches zero (Choi et al, 2001).…”
Section: Discussionsupporting
confidence: 94%
“…Inhibition of cerebral glucose utilization by hypoglycemia or pharmacological doses of 2-deoxyglucose (2-DG) has been found to result in marked increases in CBF (3,10). Inasmuch as these conditions depress cerebral energy metabolism, the increases in CBF cannot be ascribed to vasodilator products of glucose and/or oxygen metabolism.…”
Section: G -Nitro-largininementioning
confidence: 99%
“…For example, Powers et al (1996) interpreted the observation of no change in task-activated flow increases in hypoglycemia to be that blood flow is uncoupled with metabolism and neural activity in hypoglycemia. However, while such metabolism studies have provided variable results by methods of FDG PET (Horinaka et al, 1997;Wienhard, 2002), the methods of functional magnetic resonance (MR) imaging can provide an alternative approach. Therefore, in this study, we used high-field MR perfusion, R 2 0 and BOLD imaging to evaluate perfusion and oxidative metabolism in normal adult volunteers.…”
Section: Introductionmentioning
confidence: 99%